Results 191 to 200 of about 67,658 (263)

Eosinophil Peroxidase as a Dynamic Indicator of Treatment Response in Eosinophilic Chronic Rhinosinusitis

International Forum of Allergy &Rhinology, Volume 16, Issue 1, Page 110-113, January 2026.
Key Points Eosinophil peroxidase (EPX) correlates with local type 2 inflammation and may serve as a noninvasive biomarker of eosinophilic chronic rhinosinusitis. EPX declines after surgery and dupilumab, highlighting its potential to track treatment response.
Jacquelyn K. Callander, Annabelle R. Charbit, Camryn Marshall, Kritika Khanna, Steven D. Pletcher, Jose G. Gurrola II, Andrew H. Murr, Monica Tang, Andrew N. Goldberg, Patricia A. Loftus   +9 more
wiley   +1 more source

Eosinophilia and Select Parasitic Infections Among People Seeking Humanitarian Protections in the United States After Travel Through the Darién Jungle: A Multicenter Cross-sectional Study. [PDF]

Open Forum Infect Dis
Olivo-Freites C, Ascanio LC, Paniz-Mondolfi A, Suarez JA, Desai AN, Chu JT, LaRocque RC, Mohareb AM.   +7 more
europepmc   +1 more source

Nanoparticle Albumin‐Bound Paclitaxel and Nivolumab for PD‐1 Inhibitor‐Refractory Recurrent or Metastatic Head and Neck Squamous‐Cell Carcinoma

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Introduction Standard therapy for PD‐1 inhibitor‐refractory recurrent or metastatic head and neck squamous‐cell carcinoma (RM‐HNSCC) has limited activity. Drugs bound to albumin selectively target cancer cells with upregulated macropinocytosis, a process driven by constitutively hyper‐activated EGFR/RAS/PIK3CA signaling, which is common in ...
Douglas Adkins, Jessica C. Ley, Christine Auberle, Brendan Knapp, Jesse Zaretsky, Jingxia Liu, Peter Oppelt   +6 more
wiley   +1 more source

Mixed cholangiopathy with eosinophilic and autoimmune features: a case report. [PDF]

J Med Case Rep
Shen H, Commins I, Roberts SK, Karp J, Majeed A.   +4 more
europepmc   +1 more source

Chasing eosinophilia in loeffler′s syndrome: A case of strongyloidiasis in upstate New York

, 2013
Wisit Cheungpasitporn, Saeed Ahmed, Saira Rashid, Nischala Ammannagari   +3 more
openalex   +2 more sources

Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Eosinophilic fasciitis (EF) is a rare condition with an unknown cause. This case study showed that a 40‐year‐old man with EF did not respond to standard treatments but improved after receiving rituximab and intravenous immunoglobulin (IVIG). Further studies are needed to confirm rituximab's effectiveness and long‐term safety for EF.
Maryam Sahebari, Motahhareh Karimoddini, Naser Tayyebi Meibodi, Sajad Ataei Azimi, Shadan Tafreshian   +4 more
wiley   +1 more source

DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) Is More: A Rare Case of Acalculous Cholecystitis. [PDF]

ACG Case Rep J
Gupta SR, Chang A, Farrakhan K, Guo A, Nowrangi D, Moss SF.   +5 more
europepmc   +1 more source

Nasal Eosinophilia in Allergic Rhinitis: A Clinico-Correlative Observational Study

, 2016
Rajesh Radhakrishna Havaldar
openalex   +1 more source

Hydatid Cyst in a Post‐Tuberculosis Patient: A Persistent Pulmonary Puzzle – A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Pulmonary tuberculosis and hydatid cyst are two distinct pathologies with vastly different etiologies and management approaches, yet they share common risk factors and pulmonary involvement. This rare and unique case of a hydatid cyst occurring in a post‐tuberculosis patient adds to the limited literature and highlights the diagnostic and ...
Abdul Rehman Shahid, Amina Asad, Janmejay Kumar Singh, Malik Muhammad Kabir, Kainat Husain, Khalil El Abdi, Fazeela Bibi, Muhammad Hassan, Bilal Aslam, Said Hamid Sadat   +9 more
wiley   +1 more source

Case report: The diagnostic dilemma created by non-infectious diffuse abdominal pain and hypereosinophilia in a teenage boy. [PDF]

SAGE Open Med Case Rep
Nelson KA, Nong J, Murray K, Merrow AC, Hariharan S.   +4 more
europepmc   +1 more source